Neoadjuvant treatment strategies for hepatocellular carcinoma

被引：15
|
作者：
Xu, Lei [1 ]
Chen, Lin [1 ]
Zhang, Wei [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, 1095 Jie Fang Ave, Wuhan 430030, Hubei, Peoples R China
来源：
WORLD JOURNAL OF GASTROINTESTINAL SURGERY | 2021年 / 13卷 / 12期
关键词：
Hepatocellular carcinoma; Neoadjuvant therapy; Prognosis; Indications; Contraindications; PORTAL-VEIN EMBOLIZATION; DRUG-ELUTING BEADS; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; GEMCITABINE PLUS OXALIPLATIN; RECURRENCE-FREE SURVIVAL; FATTY LIVER-DISEASE; INFERIOR VENA-CAVA; TRANSARTERIAL CHEMOEMBOLIZATION; Y-90; RADIOEMBOLIZATION; CONVENTIONAL CHEMOEMBOLIZATION;
D O I：
10.4240/wjgs.v13.i12.1550
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The incidence of hepatocellular carcinoma (HCC) remains high globally. Surgical treatment is the best treatment for improving the prognosis of patients with HCC. Neoadjuvant therapy plays a key role in preventing tumor progression and even downstaging HCC. The liver transplantation rate and resectability rate have increased for neoadjuvant therapy. Neoadjuvant therapy is effective in different stages of HCC. In this review, we summarized the definition, methods, effects, indications and contraindications of neoadjuvant therapy in HCC, which have significance for guiding treatment.
引用
收藏
页码：1550 / 1566
页数：17
相关论文
共 50 条
  • [21] Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma
    Vogel, Arndt
    Saborowski, Anna
    CANCER TREATMENT REVIEWS, 2020, 82
  • [22] Targeted Drug Delivery Strategies for the Treatment of Hepatocellular Carcinoma
    Liu, Yonghui
    Wu, Yanan
    Li, Zijian
    Wan, Dong
    Pan, Jie
    MOLECULES, 2024, 29 (18):
  • [23] Current locoregional therapies and treatment strategies in hepatocellular carcinoma
    Cardarelli-Leite, L.
    Hadjivassiliou, A.
    Klass, D.
    Chung, J.
    Ho, S. G. F.
    Lim, H. J.
    Kim, P. T. W.
    Mujoomdar, A.
    Liu, D. M.
    CURRENT ONCOLOGY, 2020, 27 : S144 - S151
  • [24] New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy
    Anand, Anil C.
    Acharya, Subrat K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (03) : 284 - 287
  • [25] Impact of Neoadjuvant Treatment of Hepatocellular Carcinoma on Survival after Liver Transplantation
    Onaca, Nicholas
    Davis, Gary L.
    Jennings, Linda W.
    Goldstein, Robert M.
    Klintmalm, Goran B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 442 - 442
  • [26] Evolution of Systemic Treatment for Hepatocellular Carcinoma: Changing Treatment Strategies and Concepts
    Moriguchi, Michihisa
    Kataoka, Seita
    Itoh, Yoshito
    CANCERS, 2024, 16 (13)
  • [27] Neoadjuvant systemic therapy for hepatocellular carcinoma
    Chick, R. Connor
    Ruff, Samantha M.
    Pawlik, Timothy M.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Neoadjuvant immunotherapy for resectable hepatocellular carcinoma
    Wei, Fangqiang
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (06): : 504 - 504
  • [29] Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
    Llovet, Josep M.
    Pinyol, Roser
    Yarchoan, Mark
    Singal, Amit G.
    Marron, Thomas U.
    Schwartz, Myron
    Pikarsky, Eli
    Kudo, Masatoshi
    Finn, Richard S.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (4) : 294 - 311
  • [30] Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
    Josep M. Llovet
    Roser Pinyol
    Mark Yarchoan
    Amit G. Singal
    Thomas U. Marron
    Myron Schwartz
    Eli Pikarsky
    Masatoshi Kudo
    Richard S. Finn
    Nature Reviews Clinical Oncology, 2024, 21 : 294 - 311
12345